Overview

Cumbersome manual processes slow down the specialty medication journey.

As a patient access vendor, you have the power to unlock access to life-changing therapies for patients. But when you’re stuck manually hunting down patient benefit information, your services fall short of their potential.

Inaccurate benefit details delay therapy.

Coverage confusion, financial barriers and treatment delays can make it difficult for patients to access the specialty medications they’ve been prescribed.

Missing information and manual processes can stretch time to specialty therapy to seven weeks.1
1 in 5 insured U.S. patients say they have trouble navigating, understanding and anticipating their health insurance.2

Inefficient systems burden your team.

Faxes, phone calls, claims data—finding accurate, trusted benefit intelligence can be difficult and time consuming.

43.1 million patients in the U.S. had more than one type of health insurance coverage in 2021.3
Solutions

Accelerate patient access

  • Benefit & Price Intelligence

Benefit & Price Intelligence

Overcome patient access challenges with timely and accurate benefit insights that get patients started on treatment sooner.

Why Surescripts

A powerful partnership

Interoperability LtBlue

A single, direct connection to health plans and PBMs nationwide

Optimize speed and efficiency with accurate data from health plans and PBMs.

Data Transfer Lt Blue

Leading speed and reliability

Surescripts delivers transactions in milliseconds across a network with a 99.995% average uptime.4

Care Network 2 LtBlue

Vast network

The Surescripts Master Patient Index includes data for virtually every insured American.5

Insights

Keep pace with healthcare innovation

Footnotes
  1. PhRMA, “Patient Experience Survey — Navigating the Patient Experience: The Barriers and Burdens Standing Between Patients and Care,” September 11, 2022.
  2. Laryssa Mykyta et al., “About 43 Million People in the U.S. Had Multiple Health Plans in 2021,” Census.gov, July 19, 2023.
  3. AssistRx, "The Intelligent Way to Initiate and Advance Specialty Therapies," presented at Surescripts Specialty Medication Symposium, March 25, 2021.
  4. Surescripts, “2024 Annual Impact Report,” March 2025, p.5.
Read More
OSZAR »